Stories
Slash Boxes
Comments

SoylentNews is people

SoylentNews is powered by your submissions, so send in your scoop. Only 11 submissions in the queue.
posted by janrinok on Thursday October 15 2015, @01:03PM   Printer-friendly
from the money-makes-the-world-go-round dept.

U.S. prices for the world's 20 top-selling medicines are, on average, three times higher than in Britain, according to an analysis carried out for Reuters.

The finding underscores a transatlantic gulf between the price of treatments for a range of diseases and follows demands for lower drug costs in America from industry critics such as Democratic presidential candidate Hillary Clinton.

The 20 medicines, which together accounted for 15 percent of global pharmaceuticals spending in 2014, are a major source of profits for companies including AbbVie (ABBV.N), AstraZeneca (AZN.L), Merck (MRK.N), Pfizer (PFE.N) and Roche (ROG.VX).


Original Submission

 
This discussion has been archived. No new comments can be posted.
Display Options Threshold/Breakthrough Mark All as Read Mark All as Unread
The Fine Print: The following comments are owned by whoever posted them. We are not responsible for them in any way.
  • (Score: 3, Insightful) by pinchy on Thursday October 15 2015, @10:26PM

    by pinchy (777) on Thursday October 15 2015, @10:26PM (#250272) Journal

    People who are in the healthcare business are going to fight it tooth and nail. All these expensive hospital bills lines someones pocket. Everyone from nurses/doctors/staff on up to pharmacy. They dont want the gravy train spoiled.

    Starting Score:    1  point
    Moderation   +2  
       Insightful=2, Total=2
    Extra 'Insightful' Modifier   0  

    Total Score:   3